1.05
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché JAGX Giù?
Forum
Previsione
Frazionamento azionario
Jaguar Health Inc Borsa (JAGX) Ultime notizie
How Jaguar Health Inc. stock reacts to oil prices2025 Price Targets & Risk Controlled Daily Trade Plans - ulpravda.ru
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - Enterprise News
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Times Record News
Will Jaguar Health Inc. stock benefit from commodity prices2025 Sector Review & Risk Controlled Stock Alerts - ulpravda.ru
Aug Wrap: Will Jaguar Health Inc. (1JA0) stock extend growth story2025 Bull vs Bear & Weekly High Return Forecasts - ulpravda.ru
Why Jaguar Health Inc. stock remains on watchlistsBond Market & Weekly Setup with High ROI Potential - ulpravda.ru
Why Jaguar Health Inc. stock could see breakout soonJuly 2025 Intraday Action & Stepwise Swing Trade Plans - ulpravda.ru
Can Jaguar Health Inc. (1JA0) stock hold up in economic slowdownJuly 2025 Levels & Fast Moving Trade Plans - ulpravda.ru
Why hedge funds are buying Jaguar Health Inc. stockMarket Trend Report & High Accuracy Swing Entry Alerts - ulpravda.ru
Can Jaguar Health Inc. stock deliver sustainable ROEGDP Growth & Growth Focused Stock Pick Reports - ulpravda.ru
Will Jaguar Health Inc. (1JA0) stock extend growth storyDay Trade & Safe Capital Growth Plans - ulpravda.ru
Insider Sell: Is Jaguar Health Inc 1JA0 stock cheap vs fundamentalsTrade Risk Report & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders - The Asheville Citizen Times
Jaguar Health reports PS reduction in pediatric intestinal failure study By Investing.com - Investing.com Australia
Jaguar Health (JAGX) Reports Promising Trials for Crofelemer in UAE - GuruFocus
Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication - ACCESS Newswire
Experimental drug lets some children rely less on IV nutrition support - Stock Titan
Knight Therapeutics and Jaguar Health Announce Strategic Partnership - ACCESS Newswire
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Ventura County Star
Jaguar Health (JAGX) Secures $240,000 FDA Grant for Canine Diarr - GuruFocus
FDA backs study of new treatment for chemo-related diarrhea in dogs - Stock Titan
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts - Norwich Bulletin
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID) - Montgomery Advertiser
Aug Big Picture: Why hedge funds are buying Jaguar Health Inc stock2025 Top Gainers & Community Supported Trade Ideas - moha.gov.vn
Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026 - Burlington Free Press
What analysts say about Jaguar Health Inc stockPrice Action Analysis & Free Stock Index Interpretations - earlytimes.in
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - Press & Sun-Bulletin
Sell Signal: Why Jaguar Health Inc 1JA0 stock benefits from AI revolution2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - moha.gov.vn
Aug PreEarnings: How Jaguar Health Inc. stock reacts to oil prices2025 Investor Takeaways & Target Return Focused Stock Picks - Улправда
Can Jaguar Health Inc. stock deliver surprise earnings beatJuly 2025 News Drivers & Momentum Based Trading Ideas - Улправда
Jaguar Health Earnings Notes - Trefis
Why analysts recommend Jaguar Health Inc. (1JA0) stockJuly 2025 Retail & Real-Time Volume Analysis Alerts - DonanımHaber
Will Jaguar Health Inc. stock split attract more investorsQuarterly Market Summary & High Return Trade Opportunity Guides - DonanımHaber
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Pensacola News Journal
Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF) - Hornell Evening Tribune
Jaguar Health director gets 5,870 RSUs and 5,870 options | JAGX SEC FilingForm 4 - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):